ICAM1 and metabolic syndrome: Roy et al. [74] reported that, among patients with metabolic syndrome, increased levels of circulating sST2 correlated positively with inflammatory markers: IL-6, osteopontin, ICAM-1, myeloperoxidase and a classical reactive oxygen species marker nitrotyrosine (NT-Tyr).